Pancreatic ductal adenocarcinoma (PDA) mortality is primarily attributed to metastasis and chemotherapy resistance. In this research, the long non-coding RNA MACC1-AS1 was studied, playing a significant role in regulating lipid oxidation processes. This regulation could further lead to the inhibition of ferroptosis induced by chemotherapeutic drugs, making it a contributing factor to gemcitabine resistance in PDA. In both gemcitabine-resistant PDA patients and mouse models, the elevated expression level of MACC1-AS1 in the tumors was noted. Additionally, overexpression of MACC1-AS1 in pancreatic cancer cells was found to enhance tolerance to gemcitabine and suppress ferroptosis. Proteomic analysis of drug-resistant pancreatic cells revealed that overexpressed MACC1-AS1 inhibited the ubiquitination degradation of residues in the protein kinase STK33 by MDM4. Furthermore, its accumulation in the cytoplasm activated STK33, further activating the ferroptosis-suppressing proteins GPX4, thereby counteracting gemcitabine-induced cellular oxidative damage. These findings suggested that the long non-coding RNA MACC1-AS1 could play a significant role in the ability of pancreatic cancer cells to evade iron-mediated ferroptosis induced by gemcitabine. This discovery holds promise for developing clinical therapeutic strategies to combat chemotherapy resistance in pancreatic cancer.
14 October 2020 in Journal of Hepato-Biliary-Pancreatic Sciences
Objective: This study aims to investigate the feasibility of employing artificial intelligence models for the detection and localization of cervical lesions by leveraging deep semantic features extracted from colposcopic images.Methods: The study employed a segmentation-based deep learning architecture, utilizing a deep decoding network to integrate prior features and establish a semantic segmentation model capable of distinguishing normal and pathological changes. A two-stage decision model is proposed for deep semantic feature mining, which combines image segmentation and classification to categorize pathological changes present in the dataset. Furthermore, transfer learning was employed to create a feature extractor tailored to colposcopic imagery. Multi-scale data were bolstered by an attention mechanism to facilitate precise segmentation of lesion areas. The segmentation results were then coherently mapped back onto the original images, ensuring an integrated visualization of the findings.Results: Experimental findings demonstrated that compared to algorithms solely based on image segmentation or classification, the proposed approach exhibited superior accuracy in distinguishing between normal and lesioned colposcopic images. Furthermore, it successfully implemented a fully automated pixel-based cervical lesion segmentation model, accurately delineating regions of suspicious lesions. The model achieved high sensitivity (96.38%), specificity (95.84%), precision (97.56%), and f1 score (96.96%), respectively. Notably, it accurately estimated lesion areas, providing valuable guidance to assisting physicians in lesion classification and localization judgment.Conclusion: The proposed approach demonstrates promising capabilities in identifying normal and cervical lesions, particularly excelling in lesion area segmentation. Its accuracy in guiding biopsy site selection and subsequent localization treatment is satisfactory, offering valuable support to healthcare professionals in disease assessment and management.
15 June 2024 in World Journal of Gastrointestinal Oncology
Background: Hepatocellular Carcinoma (HCC) ranks among the most prevalent human cancers and stands as the third most common cause of death related to cancer globally. Current therapies for HCC include surgical resection, local ablation, chemoembolization, liver transplantation, and molecular‐targeted therapy. Only a small number of patients are detected in the early stage, and most patients are diagnosed at the time of the middle and late stages, thus losing the opportunity for surgical treatment, which is an essential reason for the high mortality of HCC patients. Initiating cytotoxicity in cancer cells stands as a fundamental approach for tumor treatment, with the majority of research centering on apoptosis.Aims: Since anti‐apoptotic methods often fulfill cancer cells' ability to resist anticancer drugs, research on new induction forms of regulative cell death, such as ferroptosis, is of great clinical value.Methods and Results: In this study, we employed a combination of in silico molecular docking and in vitro cell validation experiments to identify three ferroptosis suppressor genes, AR, HIF1A, and CA9, as promising components of a survival prognosis model during the metformin‐induced ferroptosis process in liver cancer. Further, we discovered that AR could achieve efficient molecular docking with Metformin among these genes. Additionally, cell experiments revealed that Metformin could downregulate the protein expression level of AR.Conclusion: This research has developed a prognostic model for ferroptosis suppressor genes through the analysis of the ferroptosis process induced by metformin in liver cancer. It also screened and validated AR as a potential molecular docking target for metformin.